Literature DB >> 27623131

The Combined Blockade of β-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer Outcomes.

Itay Ricon1, Jonathan G Hiller, Shamgar Ben-Eliyahu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27623131     DOI: 10.1097/AIA.0000000000000116

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN: 0020-5907


× No keyword cloud information.
  3 in total

1.  Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.

Authors:  Lee Shaashua; Maytal Shabat-Simon; Rita Haldar; Pini Matzner; Oded Zmora; Moshe Shabtai; Eran Sharon; Tanir Allweis; Iris Barshack; Lucile Hayman; Jesusa Arevalo; Jeffrey Ma; Maya Horowitz; Steven Cole; Shamgar Ben-Eliyahu
Journal:  Clin Cancer Res       Date:  2017-05-10       Impact factor: 12.531

Review 2.  Antitumor Anesthetic Strategy in the Perioperatory Period of the Oncological Patient: A Review.

Authors:  Sonia Santander Ballestín; Andrea Lanuza Bardaji; Cristina Marco Continente; María José Luesma Bartolomé
Journal:  Front Med (Lausanne)       Date:  2022-02-18

Review 3.  Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.

Authors:  Itay Ricon; Tsipi Hanalis-Miller; Rita Haldar; Rebecca Jacoby; Shamgar Ben-Eliyahu
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.